G&E Herbal Biotechnology Co., Ltd. (4911.TWO)

TWD 57.1

(-0.7%)

Market Cap (In TWD)

3.36 Billion

Revenue (In TWD)

181.44 Million

Net Income (In TWD)

72.4 Million

Avg. Volume

33.42 Thousand

Currency
TWD
Country
Healthcare
Open
-
Prev. Close
-
Day Range
-
Year Range
48.584904-61.7
PE
-
EPS
-
Beta Value
-0.218
ISIN
TW0004911003
CUSIP
-
CIK
-
Shares
-
Earnings Annoncement
-

Company Profile

Sector
Healthcare
Industry
Biotechnology
CEO
Mr. Kou-Wha Kou Ph.D.
Employee Count
-
Website
https://www.geherbs.com.tw
Ipo Date
2011-03-21
Details
G&E Herbal Biotechnology Co., Ltd., a biopharmaceutical company, focuses on the development and commercialization of novel botanical extraction technology and products. It offers botanical anti-aging cosmetic products, such as facial foam cleanser and cleansing essence, botanical extract toner, lightening lotion, essential oil, and moisturizing serum and cream; SR-100 botanical essence and bromelain illuminating cleansing mousse; and hepato protective agent capsules. The company also provides botanical healthcare products comprising ArthrEnergy, Jujubes Polysaccharide, Diabecut, HepatoClean, Astragali Radix, Goji, Prosta, and SR-100 capsules; and adult products. In addition, it is developing Solarise injection for the treatment of gynecologic, head, and neck cancer; Apocin capsule to treat non-small cell lung cancer; and SR-T100 Gel for the treatment of common and genital warts. Further, the company manufactures technology development for various dietary supplements, as well as provides technical advisory services to other biotechnology organizations. G&E Herbal Biotechnology Co., Ltd. was founded in 2002 and is based in Tainan City, Taiwan.